BiotechTube
YouSeq

YouSeq

Cambridge, United Kingdom· Est.
youseq.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.8M

Overview

YouSeq is a private, commercial-stage diagnostics company headquartered in Cambridge, UK, leveraging qPCR and Next-Generation Sequencing (NGS) technologies to develop multiplex test panels primarily for infectious diseases. The company emphasizes a large off-the-shelf product menu and custom panel development services, backed by ISO 13485 accreditation and a team with deep molecular diagnostics expertise. Its business model is centered on selling reagents and kits to diagnostic labs and researchers, with a growing global distribution network including US warehousing.

Infectious DiseasesOncology

Technology Platform

Multiplex qPCR and Next-Generation Sequencing (NGS) assay design and development, combined with proprietary bioinformatics for multi-target detection.

Funding History

1
Total raised:$1.8M
Seed$1.8M

Opportunities

The growing demand for syndromic infectious disease testing and the expansion of NGS into routine clinical diagnostics present significant growth avenues.
YouSeq's global distribution setup and custom panel service allow it to address diverse market needs and build sticky customer relationships.

Risk Factors

Intense competition from large diagnostics corporations and other startups threatens market share.
Regulatory hurdles for new geographies and product categories, along with the operational complexity of managing an extensive product menu, pose execution risks.

Competitive Landscape

YouSeq competes in the molecular diagnostics space against global giants like Roche, Bio-Rad, and Qiagen, as well as specialized multiplex PCR companies like BioFire Diagnostics (bioMérieux). Its differentiation hinges on the breadth of its off-the-shelf qPCR menu and its dual focus on both qPCR and NGS solutions.

More companies in United Kingdom →